AAAAAA

   
Results: 1-24 |
Results: 24
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience
Authors: Razzouk, BI Raimondi, SC Srivastava, DK Pritchard, M Behm, FG Tong, X Sandlund, JT Rubnitz, JE Pui, CH Ribeiro, RC
Citation: Bi. Razzouk et al., Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience, LEUKEMIA, 15(9), 2001, pp. 1326-1330
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma
Authors: Ribeiro, RC Fletcher, BD Kennedy, W Harrison, PL Neel, MD Kaste, SC Sandlund, JT Rubnitz, JE Razzouk, BI Relling, MV Pui, CH
Citation: Rc. Ribeiro et al., Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma, LEUKEMIA, 15(6), 2001, pp. 891-897
Second malignancy after treatment of childhood acute myeloid leukemia
Authors: Leung, W Ribeiro, RC Hudson, M Tong, X Srivastava, DK Rubnitz, JE Sandlund, IT Razzouk, BI Evans, WE Pui, CH
Citation: W. Leung et al., Second malignancy after treatment of childhood acute myeloid leukemia, LEUKEMIA, 15(1), 2001, pp. 41-45
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia
Authors: Blanco, JG Dervieux, T Edick, MJ Mehta, PK Rubnitz, JE Shurtleff, S Raimondi, SC Behm, FG Pui, CH Relling, MV
Citation: Jg. Blanco et al., Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia, P NAS US, 98(18), 2001, pp. 10338-10343
Second malignancy after treatment of childhood non-Hodgkin lymphoma
Authors: Leung, W Sandlund, JT Hudson, MM Zhou, YM Hancock, ML Zhu, YP Ribeiro, RC Rubnitz, JE Kun, LE Razzouk, B Evans, WE Pui, CH
Citation: W. Leung et al., Second malignancy after treatment of childhood non-Hodgkin lymphoma, CANCER, 92(7), 2001, pp. 1959-1966
Biology and outcome of childhood acute megakaryoblastic leukemia: a singleinstitution's experience
Authors: Athale, UH Razzouk, BI Raimondi, SC Tong, X Behm, FG Head, DR Srivastava, DK Rubnitz, JE Bowman, L Pui, CH Ribeiro, RC
Citation: Uh. Athale et al., Biology and outcome of childhood acute megakaryoblastic leukemia: a singleinstitution's experience, BLOOD, 97(12), 2001, pp. 3727-3732
Concurrent translocations of MLL and CBFA2 (AMLI) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia
Authors: Mathew, S Head, D Rubnitz, JE Raimondi, SC
Citation: S. Mathew et al., Concurrent translocations of MLL and CBFA2 (AMLI) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia, GENE CHROM, 28(2), 2000, pp. 227-232
Prognostic factors in infants with acute myeloid leukemia
Authors: Pui, CH Raimondi, SC Srivastava, DK Tong, X Behm, FG Razzouk, B Rubnitz, JE Sandlund, JT Evans, WE Ribeiro, R
Citation: Ch. Pui et al., Prognostic factors in infants with acute myeloid leukemia, LEUKEMIA, 14(4), 2000, pp. 684-687
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital
Authors: Pui, CH Boyett, JM Rivera, GK Hancock, ML Sandlund, JT Ribeiro, RC Rubnitz, JE Behm, FG Raimondi, SC Gajjar, A Razzouk, B Campana, D Kun, LE Relling, MV Evans, WE
Citation: Ch. Pui et al., Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital, LEUKEMIA, 14(12), 2000, pp. 2286-2294
Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia
Authors: Woo, MH Hak, LJ Storm, MC Sandlund, JT Ribeiro, RC Rivera, GK Rubnitz, JE Harrison, PL Wang, B Evans, WE Pui, CH Relling, MV
Citation: Mh. Woo et al., Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia, J CL ONCOL, 18(7), 2000, pp. 1525-1532
Late effects of treatment in survivors of childhood acute myeloid leukemia
Authors: Leung, W Hudson, MM Strickland, DK Phipps, S Srivastava, DK Ribeiro, RC Rubnitz, JE Sandlund, JT Kun, LE Bowman, LC Razzouk, BI Mathew, P Shearer, P Evans, WE Pui, CH
Citation: W. Leung et al., Late effects of treatment in survivors of childhood acute myeloid leukemia, J CL ONCOL, 18(18), 2000, pp. 3273-3279
Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia
Authors: Rubnitz, JE
Citation: Je. Rubnitz, Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia, J BIOL REG, 14(3), 2000, pp. 182-186
Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia
Authors: Howard, SC Gajjar, A Ribeiro, RC Rivera, GK Rubnitz, JE Sandlund, JT Harrison, PL de Armendi, A Dahl, GV Pui, CH
Citation: Sc. Howard et al., Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia, J AM MED A, 284(17), 2000, pp. 2222-2224
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Authors: Coustan-Smith, E Sancho, J Hancock, ML Boyett, JM Behm, FG Raimondi, SC Sandlund, JT Rivera, GK Rubnitz, JE Ribeiro, RC Pui, CH Campana, D
Citation: E. Coustan-smith et al., Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2591-2596
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
Authors: Coustan-Smith, E Sancho, J Hancock, ML Boyett, JM Behm, FG Raimondi, SC Sandlund, JT Rivera, GK Rubnitz, JE Ribeiro, RC Pui, CH Campana, D
Citation: E. Coustan-smith et al., Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2691-2696
Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia
Authors: Gajjar, A Harrison, PL Sandlund, JT Rivera, GK Ribeiro, RC Rubnitz, JE Razzouk, B Relling, MV Evans, WE Boyett, JM Pui, CH
Citation: A. Gajjar et al., Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia, BLOOD, 96(10), 2000, pp. 3381-3384
Significance of the TEL-AML fusion gene in childhood AML
Authors: Rubnitz, JE Downing, JR Pui, CH
Citation: Je. Rubnitz et al., Significance of the TEL-AML fusion gene in childhood AML, LEUKEMIA, 13(9), 1999, pp. 1470-1471
The role of TEL fusion genes in pediatric leukemias
Authors: Rubnitz, JE Pui, CH Downing, JR
Citation: Je. Rubnitz et al., The role of TEL fusion genes in pediatric leukemias, LEUKEMIA, 13(1), 1999, pp. 6-13
Low frequency or TEL-AML1 In relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup
Authors: Rubnitz, JE Behm, FG Wichlan, D Ryan, C Sandlund, JT Ribeiro, RC Rivera, GK Hancock, ML Relling, MV Evans, WE Pui, CH Downing, JR
Citation: Je. Rubnitz et al., Low frequency or TEL-AML1 In relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup, LEUKEMIA, 13(1), 1999, pp. 19-21
Sex differences in prognosis for children with acute lymphoblastic leukemia
Authors: Pui, CH Boyett, JM Relling, MV Harrison, PL Rivera, GK Behm, FG Sandlund, JT Ribeiro, RC Rubnitz, JE Gajjar, A Evans, WE
Citation: Ch. Pui et al., Sex differences in prognosis for children with acute lymphoblastic leukemia, J CL ONCOL, 17(3), 1999, pp. 818-824
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation
Authors: Rubnitz, JE Camitta, BM Mahmoud, H Raimondi, SC Carroll, AJ Borowitz, MJ Shuster, JJ Link, MP Pullen, DJ Downing, JR Behm, FG Pui, CH
Citation: Je. Rubnitz et al., Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation, J CL ONCOL, 17(1), 1999, pp. 191-196
High incidence of secondary brain tumours after radiotherapy and antimetabolites
Authors: Relling, MV Rubnitz, JE Rivera, GK Boyett, JM Hancock, ML Felix, CA Kun, LE Walter, AW Evans, WE Pui, CH
Citation: Mv. Relling et al., High incidence of secondary brain tumours after radiotherapy and antimetabolites, LANCET, 354(9172), 1999, pp. 34-39
Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis
Authors: Ito, C Kumagai, M Manabe, A Coustan-Smith, E Raimondi, SC Behm, FG Murti, KG Rubnitz, JE Pui, CH Campana, D
Citation: C. Ito et al., Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis, BLOOD, 93(1), 1999, pp. 315-320
Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia
Authors: Pui, CH Rubnitz, JE Hancock, ML Downing, JR Raimondi, SC Rivera, GK Sandlund, JT Ribeiro, RC Head, DR Relling, MV Evans, WE Behm, FG
Citation: Ch. Pui et al., Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia, J CL ONCOL, 16(12), 1998, pp. 3768-3773
Risultati: 1-24 |